| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 195.96B | 196.77B | 166.88B | 164.02B | 149.08B | 119.16B |
| Gross Profit | 33.52B | 34.23B | 33.40B | 34.91B | 34.77B | 26.92B |
| EBITDA | 17.74B | 18.66B | 17.19B | 19.05B | 21.05B | 13.89B |
| Net Income | 8.10B | 9.02B | 6.60B | 9.78B | 9.28B | 3.75B |
Balance Sheet | ||||||
| Total Assets | 239.46B | 240.18B | 229.58B | 208.34B | 197.73B | 188.74B |
| Cash, Cash Equivalents and Short-Term Investments | 36.57B | 38.06B | 37.41B | 40.00B | 33.22B | 35.51B |
| Total Debt | 31.66B | 24.37B | 22.16B | 22.86B | 22.96B | 23.15B |
| Total Liabilities | 87.80B | 88.20B | 78.85B | 68.92B | 71.36B | 72.32B |
| Stockholders Equity | 141.66B | 141.49B | 140.75B | 132.34B | 120.07B | 111.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.25B | 2.57B | 8.42B | 552.00M | 2.64B |
| Operating Cash Flow | 0.00 | 17.71B | 8.95B | 15.82B | 8.54B | 9.41B |
| Investing Cash Flow | 0.00 | -12.26B | -6.33B | -5.51B | -7.26B | -6.54B |
| Financing Cash Flow | 0.00 | -6.48B | -5.84B | -4.92B | -4.76B | -999.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥122.53B | 6.59 | 11.58% | 1.62% | 9.81% | 30.20% | |
68 Neutral | ¥200.00B | 16.52 | 6.77% | 2.30% | 8.19% | 34.88% | |
68 Neutral | ¥2.30T | 7.93 | 5.18% | 1.98% | 3.15% | -63.65% | |
66 Neutral | $618.35B | 3.88 | 3.12% | 2.83% | -0.64% | -65.65% | |
66 Neutral | ¥518.27B | 22.37 | 5.02% | 2.12% | -7.98% | -42.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
46 Neutral | ¥15.68B | 1.14 | -111.61% | ― | -11.92% | 61.16% |